Terms: = Breast cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Clinical Outcome
19 results:
1. Potential role of CXCR4 in trastuzumab resistance in breast cancer patients.
Kotb RM; Ibrahim SS; Mostafa OM; Shahin NN
Biochim Biophys Acta Mol Basis Dis; 2022 Nov; 1868(11):166520. PubMed ID: 35985446
[TBL] [Abstract] [Full Text] [Related]
2. Myoglobin Protects breast cancer Cells Due to Its ROS and NO Scavenging Properties.
Quinting T; Heymann AK; Bicker A; Nauth T; Bernardini A; Hankeln T; Fandrey J; Schreiber T
Front Endocrinol (Lausanne); 2021; 12():732190. PubMed ID: 34671319
[TBL] [Abstract] [Full Text] [Related]
3. Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1α/HK2.
Cao L; Wang M; Dong Y; Xu B; Chen J; Ding Y; Qiu S; Li L; Karamfilova Zaharieva E; Zhou X; Xu Y
Cell Death Dis; 2020 Feb; 11(2):145. PubMed ID: 32094325
[TBL] [Abstract] [Full Text] [Related]
4. Heregulin/ErbB3 Signaling Enhances CXCR4-Driven Rac1 Activation and breast cancer Cell Motility via Hypoxia-Inducible Factor 1α.
Lopez-Haber C; Barrio-Real L; Casado-Medrano V; Kazanietz MG
Mol Cell Biol; 2016 Aug; 36(15):2011-26. PubMed ID: 27185877
[TBL] [Abstract] [Full Text] [Related]
5. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
[TBL] [Abstract] [Full Text] [Related]
6. Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.
Jia X; Hong Q; Lei L; Li D; Li J; Mo M; Wang Y; Shao Z; Shen Z; Cheng J; Liu G
Oncotarget; 2015 Apr; 6(11):8648-62. PubMed ID: 25929338
[TBL] [Abstract] [Full Text] [Related]
7. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth.
Martinez-Outschoorn UE; Lisanti MP; Sotgia F
Semin Cancer Biol; 2014 Apr; 25():47-60. PubMed ID: 24486645
[TBL] [Abstract] [Full Text] [Related]
8. Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67.
Sato-Tadano A; Suzuki T; Amari M; Takagi K; Miki Y; Tamaki K; Watanabe M; Ishida T; Sasano H; Ohuchi N
Cancer Sci; 2013 Oct; 104(10):1380-8. PubMed ID: 23869589
[TBL] [Abstract] [Full Text] [Related]
9. The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism.
Chu K; Boley KM; Moraes R; Barsky SH; Robertson FM
Oncotarget; 2013 Mar; 4(3):446-62. PubMed ID: 23530113
[TBL] [Abstract] [Full Text] [Related]
10. Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer.
Dong M; Wan XB; Yuan ZY; Wei L; Fan XJ; Wang TT; Lv YC; Li X; Chen ZH; Chen J; Lin Q; Wen JY; Ma XK; Liu Q; Wu XY
Med Oncol; 2013 Mar; 30(1):355. PubMed ID: 23408367
[TBL] [Abstract] [Full Text] [Related]
11. CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth.
Capparelli C; Whitaker-Menezes D; Guido C; Balliet R; Pestell TG; Howell A; Sneddon S; Pestell RG; Martinez-Outschoorn U; Lisanti MP; Sotgia F
Cell Cycle; 2012 Jun; 11(12):2272-84. PubMed ID: 22684333
[TBL] [Abstract] [Full Text] [Related]
12. Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis.
Malfettone A; Saponaro C; Paradiso A; Simone G; Mangia A
BMC Cancer; 2012 Mar; 12():106. PubMed ID: 22439624
[TBL] [Abstract] [Full Text] [Related]
13. Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.
Laurinavicius A; Laurinaviciene A; Ostapenko V; Dasevicius D; Jarmalaite S; Lazutka J
Diagn Pathol; 2012 Mar; 7():27. PubMed ID: 22424533
[TBL] [Abstract] [Full Text] [Related]
14. Differential expression of HIF-1α in CD44+CD24-/low breast ductal carcinomas.
Oliveira-Costa JP; Zanetti JS; Silveira GG; Soave DF; Oliveira LR; Zorgetto VA; Soares FA; Zucoloto S; Ribeiro-Silva A
Diagn Pathol; 2011 Aug; 6():73. PubMed ID: 21824412
[TBL] [Abstract] [Full Text] [Related]
15. Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression.
Hyseni A; van der Groep P; van der Wall E; van Diest PJ
Cell Oncol (Dordr); 2011 Dec; 34(6):565-70. PubMed ID: 21732131
[TBL] [Abstract] [Full Text] [Related]
16. Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism.
Voss MJ; Möller MF; Powe DG; Niggemann B; Zänker KS; Entschladen F
BMC Cancer; 2011 May; 11():158. PubMed ID: 21535870
[TBL] [Abstract] [Full Text] [Related]
17. The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism.
Pavlides S; Tsirigos A; Migneco G; Whitaker-Menezes D; Chiavarina B; Flomenberg N; Frank PG; Casimiro MC; Wang C; Pestell RG; Martinez-Outschoorn UE; Howell A; Sotgia F; Lisanti MP
Cell Cycle; 2010 Sep; 9(17):3485-505. PubMed ID: 20861672
[TBL] [Abstract] [Full Text] [Related]
18. Immunohistochemical profiling of node negative breast carcinomas allows prediction of metastatic risk.
Giusiano S; Secq V; Carcopino X; Carpentier S; Andrac L; Lavaut MN; Allasia C; Bonnier P; Iovanna JL; Garcia S; Boubli L; Birnbaum D; Charpin C
Int J Oncol; 2010 Apr; 36(4):889-98. PubMed ID: 20198333
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract] [Full Text] [Related]
